摘要
直肠癌是常见恶性肿瘤,近年来在我国的发病率有迅速上升的趋势。随着直肠全系膜切除术(totalmesorectalexcision,TME)作为直肠癌手术金标准在临床上广泛开展,局部复发率已从20年前约25%降低至5%~10%以下。
出处
《中华放射肿瘤学杂志》
CSCD
北大核心
2013年第5期390-393,共4页
Chinese Journal of Radiation Oncology
参考文献37
-
1Kapiteijn E, Marijnen CA, Colenbrander AC, et al. Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands. Eur J Surg Oncol, 1998,24:528-535.
-
2Kapiteijn E, Putter H, van de Velde C J, et al. Cooperative Investigators of the Dutch Colorectal Cancer Group. Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in the Netherlands. Br J Surg,2002, 89 : 1142-1149.
-
3Camm/~ C, Giunta M, Fiorica F, et al. Preoperative radiotherapy for resectable rectal cancer: a recta-analysis. JAMA,2000,284 : 1008- 1115.
-
4Ceelen WP, Van Nieuwenhove Y, Fierens K. Preoperative chemoradiation versus radiation alone for stage ]/ and III resectable rectal cancer. Cochrane Database Syst Rev, 2009: CD006041.
-
5Saner R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med, 2004,351 : 1731-1740.
-
6Roh MS, Colangelo LH, O' Connell MJ, et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol,2009, 27:5124-5130.
-
7Park IJ, Kim HC,Yu CS,et al. Effect of adjuvant radiotherapy onlocal recurrence in stage 1I rectal cancer. Ann Surg 0ncol,2008, 15:519-525.
-
8Willett CG, Badizadegan K, Ancukiewicz M, et al. Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum, 1999,42 : 167-173.
-
9Merchant NB, Guillem JG, Paty PB, et al. T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy. J Gastrointest Surg, 1999,3:642-647.
-
10Kim JS, Kim NK, Min BS, et al. Adjuvant radiotherapy following total mesorectal excision for stage IIA rectal cancer:is it beneficial? Int J Colorectal Dis,2010,25 : 1103-1110.
同被引文献31
-
1付尚志.放疗对直肠癌的治疗作用[J].临床军医杂志,2007,35(5):764-767. 被引量:3
-
2Elshazly WG, Farouk M, Samy M. Preoperative concomitant radiotherapy with oral capecitabine in advanced rectal cancer within 6 cm from anal verge[J]. In J Colorectal Dis, 2009, 24 ( 4 ) : 401- 407.
-
3Roels S, Duthoy W, Haustermans K, et al. Definition and delinea- tion of the clinical target volume for rectal cancer[J]. Int J Radiat Oncol Biol Phys,2006,65(4)=1129-1142.
-
4Srivastava SP, Das IJ, Kumar A, et al. Dosimetric comparison of split field and fixed jaw techniques for large IMRT target vol umes in the head and neck[J]. Med Dosim,2011,36(1):6-9.
-
5Lee C;, Wu A, Garg M, et al. A new approach to reduce number of split fields in large field IMRT[J]. Med Dosim, 2011,36 ( 1 ) = 1-5.
-
6Yang T J, Oh J H, Apte A, et al. Clinical and dosimetric predictors of acute hematologic toxicity in rectal cancer patients undergoing chemoradiotherapy[J]. Radiother Oncol, 2014,113 ( 1 ) 29-34.
-
7Tol JP, Dahele M,Doornaert P, et al. Different treatment plan- ning protocols can lead to large differences in organ at risk spar- ing[J]. Radiother Oncol,2014,113(2) 267-271.
-
8Saenz DL,Paliwal BR,Bayouth JE. A dose homogeneity and conformity evaluation between ViewRay and pinnacle-based linear accelerator IM RT treatment plans[J]. J Med Phys,2014,39(2) :64-70.
-
9Kan MW,Wong W,Leung LH,et al. A comprehensive dosimet- ric evaluation of using RapidArc volumetric-modulated arc thera- py for the treatment of early-stage nasopharyngeal carcinoma [J]. J Appl Clin Med Phys,2012,13(6):189 202.
-
10Leicher B, Day E, Colonias A, et al. Dosimetric comparison of IMRT rectal and anal canal plans generated using an anterior dose avoidance structure[J]. Med Dosim, 2014,39 (3) : 272-275.
引证文献5
-
1吕国晓.32例局部晚期直肠癌患者术前放疗的临床疗效分析[J].哈尔滨医药,2014,34(4):294-295. 被引量:5
-
2龙仁平,刘贺.直肠癌诊疗模式转变的研究进展[J].中国临床新医学,2014,7(12):1183-1187. 被引量:3
-
3张明雷.直肠癌患者术前联合放疗化疗与单纯放疗的临床对照研究[J].继续医学教育,2015,29(4):78-79. 被引量:3
-
4滕建建,石锦平,张利文,谢秋英,叶淑敏.直肠癌腹股沟淋巴结转移术前调强放疗剂量学研究[J].中华肿瘤防治杂志,2015,22(19):1544-1547. 被引量:1
-
5雷建,杨翠颜.中低位直肠癌新辅助放化疗现状及临床价值[J].消化肿瘤杂志(电子版),2014,6(4):185-186. 被引量:4
二级引证文献16
-
1黄东华.直肠癌术前放疗进展[J].黑龙江医学,2015,39(4):342-343. 被引量:1
-
2罗香香,刘少精,郑珊,黄永善,麦燕婷.协同护理模式在直肠癌Miles术后护理中的应用[J].结直肠肛门外科,2015,21(2):154-156. 被引量:5
-
3黄凯斌,朱畅,郭春华,钟克力,夏利刚,潘凯.腹腔镜低位直肠癌根治术中保肛因素的Logistic分析[J].消化肿瘤杂志(电子版),2016,8(3):160-164. 被引量:1
-
4陈红莲.结肠造口病人心理状况评估及其护理干预[J].深圳中西医结合杂志,2017,27(3):176-177. 被引量:2
-
5李全伟,姬社青,张斌,张占东,孔烨,马飞,马奇,花亚伟.低位直肠癌新辅助治疗后Dixon术与Miles术的疗效比较[J].中华胃肠外科杂志,2018,21(6):703-705. 被引量:12
-
6孔永和,朱光明,李顺延,韩海林.卡培他滨联合放疗在术后直肠癌患者应用时对血栓形成的影响[J].血栓与止血学,2018,24(4):595-596. 被引量:1
-
7许卫东,何合良,蒋华勇,陈纲,杜峻峰.直肠癌患者术前联合放疗化疗与单纯放疗的临床效果分析[J].结直肠肛门外科,2016,22(S1):78-79. 被引量:1
-
8魏婷芳,刘晓青,吴传高.II-III 期局部晚期直肠癌术前放化疗的疗效研究[J].中外医疗,2017,36(35):30-32.
-
9黄治华,罗丹丹,倪程.探究3.0T磁共振平扫联合扩散加权成像在直肠癌诊断病情分期中的应用价值[J].消化肿瘤杂志(电子版),2019,11(3):241-244. 被引量:11
-
10黄艳艳,张咏梅,辜甜田,谢倩倩.基于“互联网+”的延续护理在直肠癌患者中应用的研究进展[J].现代临床护理,2019,18(7):53-57. 被引量:18
-
1鄂云翔,沈鹏.直肠全系膜切除术治疗直肠癌20例疗效观察[J].中国误诊学杂志,2005,5(17):3259-3260.
-
2张连贵,李可法.中西医结合治疗中晚期直肠癌疗效观察[J].中国乡村医药,1999,6(7):3-4. 被引量:1
-
3蒋雪超,张道全.新辅助放化疗联合直肠癌根治术治疗中晚期直肠癌的临床疗效观察[J].中国医师进修杂志,2013,36(17):10-14. 被引量:9
-
4霍丹,张高,张小丽,马玉芳,王继红.艾迪注射液联合放疗治疗中晚期直肠癌疗效观察[J].浙江中西医结合杂志,2012,22(3):185-187. 被引量:4
-
5刘俊,张开军,翟志刚,游涛,戴东方.术前同步放化疗治疗局部中晚期直肠癌的疗效及预后影响因素[J].实用临床医药杂志,2014,18(23):148-149. 被引量:15
-
6于俊兰,罗成华,李荣.中晚期直肠癌的综合治疗现状[J].华北国防医药,2002,14(5):319-321.
-
7李小武,范立,韩晓栋.中晚期直肠癌术前同步放化疗近期疗效观察[J].山西医科大学学报,2011,42(8):685-688. 被引量:5
-
8关震,刘伟利.直肠癌延误诊断51例原因分析[J].中国误诊学杂志,2007,7(24):5714-5714.
-
9邓业巍.直肠全系膜切除术在直肠癌保肛术中应用[J].医药论坛杂志,2006,27(15):96-96. 被引量:1
-
10马金才,赵启飞,等.局部注射治疗低位中晚期直肠癌12例[J].中国肛肠病杂志,2002,22(2):26-26.